Advances like these lead me to believe that useful quantum computing is inevitable and increasingly imminent. And that’s good news, because the hope is that they will be able to perform calculations that no amount of AI or classical computation could ever achieve.

Recently, Nvidia (NASDAQ: NVDA) CEO Jensen Huang made a head-turning, market-moving comment regarding his thoughts on quantum computing. Stocks in this space sold off in response. Even so, I predict that in 2025 quantum computing will emerge as one of the ...

Artificial intelligence (AI) and quantum computing investing are two incredibly popular trends. Alphabet has significant investments in both fields and is a smart way to play both trends while also cashing in on its existing business.

Jensen Huang’s comments at last week’s CES about quantum computing being decades away stirred up discussion within the quantum industry.

The model was developed by the Chinese AI startup DeepSeek, which claims that R1 matches or even surpasses OpenAI’s ChatGPT o1 on multiple key benchmarks but operates at a fraction of the cost.

IonQ (NYSE: IONQ) has been a divisive stock ever since its public debut in October 2021. The bulls were dazzled by the quantum computing company's growing list of contracts and bold claims of miniaturizing quantum processing units (QPUs), but the bears were skeptical about its ambitious growth plans.

DeepSeek AI, favored by investors over ChatGPT, uses rapid advancements with cheaper chips as U.S. tech restrictions fuel China’s AI innovation.

The shares of quantum company shares sank on Monday after Chinese AI startup DeepSeek released a reasoning that outperformed Microsoft-backed (MSFT) OpenI latest offering in many third-party tests, sparking about American dominance in the AI sector.

One Analyst Firm Just Ranked Nvidia and Alphabet as Its Top 2 "Magnificent Seven" Stocks for 2025. Are Both Stocks Buys?

Nvidia the artificial intelligence titan, is on a downward spiral as investors react to the possibility of reduced spending in AI.

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum computing and artificial intelligence to transform the drug discovery pipeline.